Schubert, C., Chatain, N., Braunschweig, T., Schemionek, M., Feldberg, K., Hoffmann, M., . . . Koschmieder, S. (2017). The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients. Oncotarget.
Citação norma ChicagoSchubert, Claudia, et al. "The SCLtTAxBCR-ABL Transgenic Mouse Model Closely Reflects the Differential Effects of Dasatinib On Normal and Malignant Hematopoiesis in Chronic Phase-CML Patients." Oncotarget 2017.
Citação norma MLASchubert, Claudia, et al. "The SCLtTAxBCR-ABL Transgenic Mouse Model Closely Reflects the Differential Effects of Dasatinib On Normal and Malignant Hematopoiesis in Chronic Phase-CML Patients." Oncotarget 2017.